Clinical Communications Programs with Healthcare Professionals and Patients
|
|
- Oswald Gordon
- 8 years ago
- Views:
Transcription
1 A Multichannel Approach Clinical Communications Programs with Healthcare Professionals and Patients A Publicis Touchpoint Solutions White Paper Best Practices Series 2011 Publicis Touchpoint Solutions, Inc.
2 2 Clinical Communications Programs with Healthcare Professionals and Patients: A Multichannel Approach Introduction Thelifesciencesindustryiscontinuingtoexpandtheclinicalcommunicationsfunction.Despiteindustry wide restructuringandongoingbudgetconsolidation,in2011 nearlyone thirdofcompaniesanticipateanincrease inmedicalaffairsfundingofmorethan10%. 1 Thiswhitepaperexplores: Themarketforcesthataredrivingtheexpansionofclinicalcommunicationsprograms, Themostcommonclinicalcommunicationstasksandroles, Guidelinesforavoidinglegalandregulatorypitfallsinaclinicalcommunicationsprogram,and Optionsforoutsourcingtheclinicalcommunicationsfunction corporate life sciences leaders across the country and around the world are searching for a new business model that will replace the 50-year-old blockbuster-based system that served the industry so well in the past.
3 3 Powerful Market Forces Are Driving Clinical Communications Growth The current business environment presents a host of difficult challenges for traditional company to healthcare professional (HCP) and company to patient interactions: Poor public perception of life sciences companies Restricted access to many institutions and some HCPs Significant restructuring and reduction of life sciences sales forces Rapid rise of Risk Evaluation and Mitigation Strategy (REMS) programs Complex state and local regulations and reporting requirements In response to these challenges, corporate life sciences leaders across the country and around the world are searching for a new business model that will replace the 50 year old blockbuster based system that served the industry so well in the past. While there are no simple answers, recent expert opinions yield three strategies that may help point the way: (1) mitigate key ongoing risks, (2) strengthen relationships with specialists and key opinion leaders (KOLs), and (3) intensify the focus on patients and health outcomes. Mitigate Key Ongoing Risks According to Christopher Bowe, US healthcare analyst for Informa s Scrip Intelligence, the new business model that emerges will be the one that is best able to mitigate key ongoing risks, including regulatory, safety, communication, public policy, and manufacturing risks. 2 A well developed clinical communications program can help mitigate at least four of these five risks: 1. Regulatory 2. Safety 3. Communication 4. Public policy Strengthen Relationships With Specialists and KOLs A second way of developing a new business model is through the lens of stakeholder influence, which is undergoing a seismic shift. As detailed in Big Pharma s Market Access Mission, a 2011 Monitor white paper, Many of today s patients are deeply engaged in their own health care, as evidenced by dramatic increases in patient-driven research and communication, patient-initiated self-diagnosis, and patient-guided prescribing. As a result, the empowered patient has become a dominant industry force.
4 cost controls and strict formularies are causing a significant shrink in the influence of primary care physicians (PCPs). But not all HCPs are seeing their influence wane. On the contrary, medical specialists and KOLs continue to wield significant influence over drug access; in fact, KOL influence is growing rapidly. 3 (See Figure 1 below.) For life sciences companies, this shift highlights how important it will be going forward to strengthen relationships with specialists and KOLs. And, of course, this is one of the primary functions of many clinical communications programs. 4 Intensify the Focus on Patients and Health Outcomes Many of today s patients are deeply engaged in their own health care, as evidenced by dramatic increases in patient driven research and communications, patient initiated self diagnosis, and patient guided prescribing. As a result, the empowered patient has become a dominant industry force. According to James Datin, executive VP and managing director of the Life Sciences Group at Safeguard Scientifics, which provides capital to entrepreneurial life sciences companies, The two major events in the last 10 years that created a shift in the life sciences industry were the rise of consumer advertising and the Internet s effect on patients. 4 There is little doubt that the industry s new business model will compel life sciences companies to focus on patients. Clinical communications programs directly support this objective. In an effort to take a step toward the new business model, many life sciences companies are working overtime to mitigate risks, strengthen relationships with specialists and KOLs, and focus on patients. One of the strategies that can help accomplish these goals is to create a strong team of clinical communications specialists.
5 5 Clinical Communications Specialists Tasks and Roles Awell developedteamofclinicalcommunicationsspecialistscanexecuteavarietyoftasks: IdentifyingandinteractingwithKOLs Placingandsupportingclinicaltrials Improvinghealthoutcomesandadherence/retentionbyeducatingHCPs,patients,andcaregivers Supportingbrandsthroughtheentirelifecycle:prelaunch,launch,growth,andmaturity Respondingtoshort termopportunitiesandthreats Providingsupporttokeyspecialistsinmetroareas,institutions,andwhitespace ParticipatinginRiskEvaluationandMitigationStrategy(REMS)strategies ThethreemostcommonclinicalcommunicationsrolesareMedicalScienceLiaisons(MSLs),ClinicalHealth Educators(CHEs),andinsideClinicalHealthAssociates(CHAs):
6 6 Medical Science Liaisons MSLs are credentialed health professionals (including MD, PhD, PharmD, RPh, RN, etc) who interact with targeted HCPs in a nonpromotional manner. MSLs are most often field based, locally focused, full time team members. However, some companies are beginning to deploy MSLs in less traditional work settings; some MSLs work part time schedules, and others conduct all or part of their HCP interactions remotely (via teleconference, online, or live video). Regardless of their schedules or geographic settings, all MSLs work to accomplish a variety of goals: KOL and specialist education Clinical trial support Speaker training and support Managed markets support REMS and safety program participation Cost effectiveness and outcomes research Clinical Health Educators CHEs are credentialed life sciences professionals (eg, nurses, diabetes educators, respiratory therapists, dietitians, etc, depending on the disease state being supported) who interact with HCPs and patients in a nonpromotional manner. Like MSLs, CHEs are often field based, locally focused, full time team members. However, some CHEs work part time schedules, and others conduct some or all of their HCP and patient interactions remotely (via teleconference, online, or live video). Regardless of their schedules or geographic settings, all CHEs work to accomplish a variety of goals: HCP education Patient and caregiver education Advocacy group education Adherence and persistency program support REMS and safety program participation As they develop clinical communications programs, life science companies must take steps to avoid legal and regulatory pitfalls.
7 7 Inside Clinical Health Associates Inside CHAs are non credentialed communications specialists who interact with HCPs and patients in a nonpromotional manner. Inside CHAs conduct all of their HCP and patient interactions remotely (via teleconference, online, or live video). CHA responsibilities and work schedules are highly project specific. For instance, some situations call for all or mostly outbound communications, while others require all or mostly inbound communications. Inside CHAs can also work in conjunction with both field based and inside CHEs as part of a comprehensive clinical health communications program. Depending on the specific need, CHAs typically work to accomplish one or more of several goals: Patient education Patient support Help desk staffing and triage Adherence and persistency program support Together, proficient teams of MSLs, CHEs, and CHAs can add significantly to a company s return on education (ROE). But before those ROE gains can be realized, significant implementation challenges must be negotiated successfully.
8 8 Guidelines for Implementing a Clinical Communications Program As they develop clinical communications programs, life science companies must take steps to avoid legal and regulatory pitfalls. McGuireWoods, a law firm with expertise in this area, provides eight important guidelines that directly support this need. 5 Although the McGuireWoods guidelines are specifically addressed to MSL teams, they can be applied to the entire range of clinical communications roles: 1. Establish Communication Specific Standard Operating Procedures (SOPs) SOPs are particularly useful in three key communication situations: (1) interactions with the sales force, (2) interactions regarding the company s investigator initiated trial program, and (3) interactions at continuing education events. 2. Correctly Align Reporting Responsibility Although the Office of Inspector General (OIG) does not dictate reporting responsibilities, many companies decide it is best for their clinical communications teams to report to the medical affairs department. If clinical communications personnel report to a company s commercial operation, critics may mischaracterize the team s tasks. In contrast, responsibility to medical affairs more clearly evidences the nonpromotional communications role. 3. Establish SOPs for Dissemination of Off Label Information Companies should ensure that their off label dissemination policies address activities conducted by the clinical communications team and incorporate the latest FDA guidance. 4. Routinely Examine Compensation Methodologies Clinical communications personnel should never be compensated based on sales performance or prescription volume goals. Companies should constantly monitor compensation methodologies to eliminate any metrics that critics could say improperly reward clinical communications staff for questionable conduct. 5. Create Guidelines Applicable to Information Exchange Regarding Unapproved Drugs Clinical communications team members must be made aware of the promotional restrictions surrounding unapproved drugs, and caution must be exercised to avoid engaging in promotional activity. Those team members who are allowed to discuss pipeline products should be given all available information regarding the pipeline, both positive and negative. an increasing number [of companies] are choosing to employ an outsourced partner to provide [the clinical communications] function.
9 9 6. ReviewInteractionsBetweenSalesForceandClinicalCommunicationsSpecialists LifesciencecompaniesshouldconsiderestablishingclearinteractionSOPsbothforthesalesforceand forclinicalcommunicationsstaff.clinicalcommunicationspersonnelmustneverbeallowedtoserve(or appeartoserve)asatoolofthesalesdepartment. 7. CreateGuidanceforInteractionsRegardingInvestigator InitiatedTrial(IIT)Programs WhilenotallclinicalcommunicationsteammemberswillhaveroutineinvolvementwithIITs,clear guidanceisnecessary.teammembersmustavoid seeding trialideaswithkols. 8. AvoidInvolvementinPromotionalContext Companiesshouldtakestepstodistancetheirclinicalcommunicationspersonnelfrompromotional activities.forexample,clinicalcommunicationsstaffshouldbediscouragedfromjoiningsalesforce personnelatgrouppromotionalevents.similarly,theyshouldusuallybediscouragedfromjoiningthe salesforceonsalescalls. Asevidencedbytheseguidelines,theproperestablishmentofaclinicalcommunicationsprogramcanbea dauntingchallenge.despitethenumeroushurdles,somecompaniescontinuetomanagetheirclinical communicationsteamsinternally.however,anincreasingnumberarechoosingtoemployanoutsourced partnertoprovidesomeofthisfunction.
10 10 Outsourcing Clinical Communications Teams Lifesciencescompaniesbeganseveralyearsagotoincreasinglyrelyonoutsourcedprovidersforclinical researchandformanufacturing;thesetrendscontinueunabated.anotherbusinessfunctionthatiswell suitedtooutsourcingisnon promotionalcommunications,includingthoseinwhichmsls,ches,andchas areinvolved. Theidealclinicalcommunicationsoutsourcingsolutionistoworkwithapartnerthatprovidesatrue multichannelarrayofclinicalcommunicationsofferings.amultichannelpartnerofferstwoimportant advantages: 1. Theabilitytoimplementflexibleclinicalcommunicationsprogramming includingmsls,ches,and CHAs thatcanrespondtoavarietyofneedsthroughouttheentireproductlifecycle 2. Theabilitytoprovideimportantsupportservices,includingclinicaloperations,recruiting,training,and informationtechnology(eg,ipad/androidtablets,othermobiledevices,onlineapplicationsand communities,etc) Whileseveraloutsourcingcompaniesprovidestand aloneteamsofmsls,ches,orchas,onlyafewoffertrue multichannelprogrammingandsupportservices.
11 11 Summary Many life sciences companies deploy MSLs, CHEs, and CHAs to mitigate risk, develop strong relationships with specialists and KOLs, and intensify the focus on patients and health outcomes. Life sciences companies must take steps to avoid legal and regulatory pitfalls in designing and implementing their clinical communications programs. Many are using outsourced partners to deploy MSLs, CHEs, and CHAs. For those who wish to outsource these roles, the ideal solution is to work with a clinical solutions partner that provides a true multichannel array of clinical communications offerings. References Best Practices, LLC press release. medical affairs functions geta boost in budget staffing.html. Accessed May 30, Primary Challenges in the Pharmaceutical Industry. A Forum white paper. 2011, 3. Big Pharma s Market Access Mission, a Monitor white paper, The ABCs of Marketing Advertising, Branding, and the CUSTOMER. PharmaVoice. March 2011, 5. Part 1: resources/item.asp?item=2397. Part 2: , McGuireWoods Web site. Accessed May 30, 2011.
12 12 Publicis Touchpoint Solutions, Inc Floral Vale Blvd. Suite 400 Yardley, PA Publicis Touchpoint Solutions, Inc
Implementing a Medical Science Liaison Team
Implementing a Medical Science Liaison Team A Publicis Touchpoint Solutions White Paper Best Practices Series 2011 Publicis Touchpoint Solutions, Inc. Implementing a Medical Science Liaison Team 2 Introduction
More informationMedical Science Liaison (MSL): Understanding, Engaging and Interacting. Gill Logan Regional Medical Affairs Manager Takeda UK
Medical Science Liaison (MSL): Understanding, Engaging and Interacting Gill Logan Regional Medical Affairs Manager Takeda UK Date of upload, October 2011 Disclosures Takeda UK employee Member of the MSLA
More informationAmgen GLOBAL CORPORATE COMPLIANCE POLICY
1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers and temporary staff worldwide ( Covered Persons ). Consultants, contract workers,
More informationField-Alternative Channels
Enhancing the Message Delivery Mix Field-Alternative Channels A Publicis Touchpoint Solutions White Paper Best Practices Series 2011 Publicis Touchpoint Solutions, Inc. 2 Field-Alternative Channels Enhancing
More informationCustomer Engagement in Healthcare
Customer Engagement in Healthcare July 7, 2014 2014 Publicis Touchpoint Solutions, Inc. Today s Discussion Welcome The Healthcare Marketplace Who Is Touchpoint? The 100% Healthcare Contact Center The Future
More information3. HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION
1. PURPOSE It is the goal of UCB, Inc. (UCB) to ensure that its marketing and promotional activities comply with all applicable state and federal laws. In addition, UCB Inc. endeavors to conform to pertinent
More informationOncology Spotlight Early Commercialization Case Study. Susie Newton RN, MS, AOCN, AOCNS: Senior Director Quintiles Health Management Solutions
Oncology Spotlight Early Commercialization Case Study Susie Newton RN, MS, AOCN, AOCNS: Senior Director Quintiles Health Management Solutions Objectives Demonstration of the need for early commercialization
More informationWhat Physicians Want! Survey
2012 What Physicians Want! Survey A Publicis Touchpoint Solutions White Paper 2012 Publicis Touchpoint Solutions, Inc. 2 Table of Contents Overview... 3 Overarching Message: Help Me Help My Patients!...
More informationThe Role of Regional Medical Advisor (RMA)-Field Medical. Dr. Aju Abraham Varghese Pfizer India. Feb 22 nd 2014
The Role of Regional Medical Advisor (RMA)-Field Medical Dr. Aju Abraham Varghese Pfizer India Feb 22 nd 2014 Disclaimer The opinions expressed in this presentation are solely those of the presenter and
More informationMedical Information Role in the Pharmaceutical Industry
www.arisglobal.com A White Paper Presented By ArisGlobal Medical Information Role in the Pharmaceutical Industry by Ome Ogbru, PharmD, Medical Information, SME What is Medical Information Overview Medical
More informationA Primer: Solving the Unique Problems of Orphan Drug Communications Programs
A Primer: Solving the Unique Problems of Orphan Drug Communications Programs Introduction When communicating about orphan diseases and development of pharmaceuticals, it is essential to recognize the special
More informationI am not a prospect I am a partner
IntelliRx, Transforming Prospect to Partner I am not a prospect I am a partner Scalable Systems Life Science & Healthcare Practices Improve Your DNA Data, Numbers & Analytics Intelli Rx Scalable Systems
More informationImpact of Clinical Education as Part of a Multichannel Sales Strategy
Impact of Clinical Education as Part of a Multichannel Sales Strategy June 13, 2012 Copyright 2012 Quintiles Topics Impact of Clinical Education as part of a Multichannel Sales Strategy -Introduction to
More informationLIBRARY GUIDE: Pharmaceutical Sales & Marketing
LIBRARY GUIDE: Pharmaceutical Sales & Marketing Page 2 Pharmaceutical Sales and Marketing Course Library Table of Contents: Courses Listed by Functional Area... 4 Basics of the PhRMA Code (PHSM01)...5
More informationBlack Mountain Consulting Group. Not just Knowledge..Know-How
Black Mountain Consulting Group Not just Knowledge..Know-How BMCG in a Nutshell. A collaborative of more than 45 Pharmaceutical Industry experts, each with more than 10 years of success in their well defined
More informationU.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT
U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT Effective: January 1, 2009 U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT January 1, 2009 I. INTRODUCTION Table of Contents II. COMPLIANCE
More informationOral Oncology Treatment Regimens and the Role of Medication Therapy Management on Patient Adherence and Compliance
Oral Oncology Treatment Regimens and the Role of Medication Therapy Management on Patient Adherence and Compliance Oral Cancer Care Therapies: The Opportunity and The Challenge Chemotherapy used to treat
More informationEngaging Clinical Trial Sites:
WHITE PAPER Engaging Clinical Trial Sites: The Role of the Clinical Trial Liaison Author: MARTIN LEE, MD Vice President, Global Scientific Affairs PRA Health Sciences Key Customers in Clinical Research
More informationMA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations
MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations Pri-Med Institute Marissa Seligman, PharmD mseligman@pri-medinstitute.org DISCLAIMER: For informational
More information4 Trends Driving New Opportunities for Engaging Physicians in Organized Provider Systems
Working the System 4 Trends Driving New Opportunities for Engaging Physicians in Organized Provider Systems Key findings from Capgemini Consulting and Quantia study (N=2,996) October 2014 page 2 of 9 Trend
More informationNutraceutical Medical Research, LLC. By: Latesha Richards, Marketing Coordinator
The Value of Conducting Post-Marketing Clinical Research On Marketing Strategy Development Nutraceutical Medical Research, LLC By: Latesha Richards, Marketing Coordinator Those of us who are marketing
More informationUse of Social Media by Pharmaceutical Medical Information Teams
www.arisglobal.com A White Paper Presented By ArisGlobal Use of Social Media by Pharmaceutical Medical Information Teams Ome Ogbru, PharmD, Medical Information SME What is Social Media? The Merriam-Webster
More informationBusiness Conduct Standards for Interactions with Healthcare Professionals. Pocket Guide for U.S. Sales Professionals. Do The Right Thing
Business Conduct Standards for Interactions with Healthcare Professionals Pocket Guide for U.S. Sales Professionals Do The Right Thing As Amgen s Vice President of Sales and Marketing Operations and Planning,
More informationCareers in Medical and Scientific Writing
Careers in Medical and Scientific Writing Laura McCormick, PhD Vice President Associate Practice Leader Tamara Fink, PhD Associate Scientific Director ProEd Communications, Inc Beachwood, Ohio Agenda Introduction
More informationKeeping our Focus: Compliance Summary for Customers and Health Care Professionals. Understanding the Olympus Health Care Compliance Code of Conduct
Keeping our Focus: Compliance Summary for Customers and Health Care Professionals Understanding the Olympus Health Care Compliance Code of Conduct Introduction Olympus Corporation of the Americas ( Olympus
More information10/31/2014. Medication Adherence: Development of an EMR tool to monitor oral medication compliance. Conflict of Interest Disclosures.
Medication Adherence: Development of an EMR tool to monitor oral medication compliance Donna Williams, RN PHN Carol Bell, NP MSN Andrea Linder, RN MS CCRC Clinical Research Nurses Stanford University SOM
More informationTen Steps in Evaluating a Life Sciences Contact Center
Ten Steps in Evaluating a Life Sciences Contact Center A Publicis Touchpoint Solutions White Paper 2013 Publicis Touchpoint Solutions, Inc. 2 Ten Steps in Evaluating a Life Sciences Contact Center In today
More informationBayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code 119400-119402
Bayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code 119400-119402 I. INTRODUCTION Bayer HealthCare LLC [including Bayer HealthCare LLC Dermatology Division
More informationCORPORATE INTEGRITY AGREEMENT
CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND GLAXOSMITHKLINE LLC I. PREAMBLE (GSK) hereby enters into this Corporate Integrity
More informationMedical Information and Pharmacovigilance through acquisition. Lisa Hughes Medical Affairs Manager Actavis UK Ltd
Medical Information and Pharmacovigilance through acquisition Lisa Hughes Medical Affairs Manager Actavis UK Ltd Disclaimer The views and opinions expressed in the following presentation are those of the
More informationComments on the 21 st Century Cures: Digital Health Care
Comments on the 21 st Century Cures: Digital Health Care July 22, 2014 The Pharmaceutical Research and Manufacturers of America (PhRMA) appreciates the opportunity to provide input to the House Energy
More informationAddressing the New Era of Life Sciences Sales Force Performance
Addressing the New Era of Life Sciences Sales Force Performance How an Emerging Synergy Between CRM, Reporting and Business Intelligence Can Empower Today s Sales Organizations 2014 CEGEDIM RELATIONSHIP
More informationPharmaceutical Medical Information Contact Centers: Results of Three Benchmarking Surveys
d r u g i n f o r m a t i o n 569 Pharmaceutical Medical Information Contact Centers: Results of Three Benchmarking Surveys Pete Guillot, MBA, RAC President, CenterFirst Consulting, LLC, Indianapolis,
More informationFive things your company needs to do to prepare for the influence of Accountable Care Organizations
Five things your company needs to do to prepare for the influence of Accountable Care Organizations An extract from Pricing & Market Access Outlook 2013 Edition Five things your company needs to do to
More informationMA Healthcare Reform Legislation: Overview of Massachusetts Department of Public Health Regulations
MA Healthcare Reform Legislation: Overview of Massachusetts Department of Public Health Regulations Melissa J. Lopes, Deputy General Counsel Massachusetts Department of Public Health Marissa Seligman,
More informationGSK Code of Practice for promotion and customer interactions
GSK Code of Practice for promotion and customer interactions Effective 21 July 2014 GSK Code of Practice GSK s interaction with external communities and the marketing of our products to ensure their appropriate
More informationSelect Healthcare Themes and Investment Opportunities
Select Healthcare and Demographic Shift Towards Older Population There were around 40 million Americans that are 65 and older in 2010 2 The population of seniors 65 and older is set to grow to 55 million
More informationCloud Marketing: Faces in the Cloud
Robert Groebel September 25, 2015 Features Cloud Marketing: Faces in the Cloud Share this article: facebook twitter linkedin google Comments Email Print As the need for more informed conversations with
More informationSpecialty Pharmacy? Disclosure. Objectives Technician
Disclosure What s so SPECIAL about? I have no actual or potential conflict of interest in relation to this program/presentation. Michael DeCoske, PharmD, BCPS Associate Chief Pharmacy Officer Duke University
More informationMarket Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform
Market Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform By Joakim Steen Mikkelsen, Managing Healthcare Counselor, Embassy of
More informationSafety Risk Management Company Perspective
Safety Risk Management Company Perspective Akihisa Harada, MD, Ph.D VP, Development Japan Pfizer Japan Inc. R&D Head Club Agenda REMS in FDAAA Safety Risk Management throughout a Drug s Lifecycle Risk
More informationCourse Certificate In. Pharmaceuticals and Medical Research: Clinical Research Monitoring & Coordination
Course Certificate In Pharmaceuticals and Medical Research: Clinical Research Monitoring & Coordination Welcome to the latest in distance learning courses designed to prepare you, on your own schedule,
More informationInstitute for Safe Medication Practices
Institute for Safe Medication Practices 1800 Byberry Road, Suite 810 Huntingdon Valley, PA 19006 FOR MORE INFORMATION, CONTACT : Michael A. Donio, MPA Marketing & Consumer Affairs 215-947-7797 Mdonio@ismp.org
More informationDespite incipient signs of leveling off, pharmaceutical rep
ACCESSMONITOR 2014 EXECUTIVE SUMMARY If Physicians Aren t Listening to Sales Reps, What Are They Listening To? Despite incipient signs of leveling off, pharmaceutical rep access to physicians continues
More informationPrescription drug costs continue to rise at
Prescription Drugs Developing an Effective Generic Prescription Drug Program by John D. Jones Pharmacy benefit managers (PBMs) use a variety of pricing strategies. When employers have a thorough knowledge
More informationDigital Pharma. What Impact on the Business Organization?
Digital Pharma What Impact on the Business Organization? About Kurt Salmon Kurt Salmon is a management consultancy focused on business transformation. Our 1,400 consultants advise companies top management
More informationLife Sciences. White Paper. Integrated Digital Marketing: The Key To Understanding Your Customer
Life Sciences White Paper Integrated Digital Marketing: The Key To Understanding Your Customer About the Authors Raghunandan H Head, Life Sciences Sales & Marketing Center of Excellence Raghunandan (Raghu)
More informationState Marketing Law Compliance: Implications of Federal Sunshine Act Preemption
State Marketing Law Compliance: Implications of Federal Sunshine Act Preemption Ronald L. Wisor, Partner February 19, 2013 Health / United States Agenda Types of state marketing laws State-specific requirements
More informationAssociate Group Director, Regulatory Intelligence & Policy
Date: 06/24/16 Associate Group Director, Regulatory Intelligence & Policy Job ID: 2974410847 Job Function Project Management Regulatory Affairs Location United States - District of Columbia Washington
More informationPractical Implementation of Risk Evaluation And Mitigation Strategies in Health Systems: The Experts Answer Your Questions
Practical Implementation of Risk Evaluation And Mitigation Strategies in Health Systems: The Experts Answer Your Questions Faculty James M. Hoffman, Pharm.D., M.S., BCPS Medication Outcomes and Safety
More informationTargeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia EXECUTIVE SUMMARY. New England Healthcare Institute
Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia New England Healthcare Institute NEHI Innovation Series March 2004 Executive Summary From drugs and medical devices, to information
More informationHow To Use Ehr For Health Care
Increase Patient Impact Via Electronic Health Records (EHR) October 1, 2014 Mukesh Mehta, DPh, MBA, RPh Vice President, Clinical & Regulatory Solutions 201.358.7538 mukesh.mehta@pdr.net Dale Cooke, PhillyCooke
More informationWE ANSWER QUESTIONS THAT NO ONE ELSE CAN. 68 T.W. Alexander Dr. P.O. Box 13628 Research Triangle Park, NC 27709 www.cuttingedgeinfo.
MEDICAL INFORMATION AND CALL CENTER PERFORMANCE BUILDING NEW PRACTICES TO MEET THE EVOLVING NEEDS OF HCPS AND PATIENTS FULL TABLE OF CONTENTS & CHARTS AND GRAPHICS 68 T.W. Alexander Dr. P.O. Box 13628
More informationPerformance Management in Medical Affairs Kinapse Consulting, 2011
Kinapse Consulting, 2011 Advise Build Operate www.kinapse.com As Medical Affairs evolves and takes a more prominent role in the development and commercialisation of medicines, it needs a more robust approach
More informationClinical Trials. Cancer Care. Well Respected. Well Connected ṢM. More answers to beat cancer.
Clinical Trials More answers to beat cancer. Cancer Care Well Respected. Well Connected ṢM Clinical research means more options and new hope. Ingalls Cancer Care connects patients to more options. Ingalls
More informationEmpowering Global Medical Information Teams with Software Solutions
www.arisglobal.com A White Paper Presented By ArisGlobal Empowering Global Medical Information Teams with Software Solutions by Ome Ogbru, PharmD, Medical Information, SME Empowering Global Medical Information
More informationTaking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset
Taking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset Introduction In this era of strategic development deals, inventiv Health has significantly broadened
More informationAstraZeneca US Compliance Program
AstraZeneca US Compliance Program Key Objectives AstraZeneca's US Compliance Program is focused on two equally important objectives: Exercising due diligence to prevent, detect and correct unlawful conduct
More informationAn Introduction to Sustainability Reporting. What Is Sustainability Reporting. White Paper: An Introduction to Sustainability Reporting
An Introduction to Sustainability Reporting There is a growing movement, worldwide, to not only be a more responsible corporate citizen, but to trade on that fact and Sustainability Reporting is the lynchpin
More informationNovel Opportunities for Engagement Utilizing in House Pharmacy Services
Novel Opportunities for Engagement Utilizing in House Pharmacy Services Ray Bailey, BSPharm RPh Director of Pharmacy, FCS Rx to Go Pharmacy rbailey@flcancer.com Angel Aslo, Pharm.D. Director of Pharmacy,
More informationAdvancing Analytics in Your Organization
Advancing Analytics in Your Organization Sarah Shillington Leidos Health, EVP Annette Savage Leidos Health, Senior Solutions Manager Bryan Fiekers HIMSS Analytics, Director leidoshealth.com Uniting 25
More informationTelehealth Solutions Enhance Health Outcomes and Reduce Healthcare Costs
Text for a pull out can go heretext for a pull out can go heretext for a pull out can go Text for a pull out can go here Text for a pull out can go here Telehealth Solutions Enhance Health Outcomes and
More informationA PASSION FOR INTEGRITY. Every Day Health Care Compliance. Code of Conduct
A PASSION FOR INTEGRITY Every Day Health Care Compliance Code of Conduct Health Care Compliance Is Everyone s Responsibility Johnson & Johnson Pharmaceutical Affiliates are known the world over for innovative,
More informationMOBILE MEDICAL APPLICATIONS
October 7, 2013 EVOKE HEALTH POINT OF VIEW MOBILE MEDICAL APPLICATIONS FDA GUIDANCE FOR INDUSTRY FOR MORE INFORMATION: Mark McConaghy, VP, Strategy Evoke Health 267.765.4998 mark.mcconaghy@evokehealth.com
More informationHow To Understand And Understand Biosimilars
Welcome to Biosimilars 20/20, presented by the Specialty Pharma Education Center (SPEC) in partnership with the Specialty Pharma Journal (SPJ). Please note that this is a preliminary agenda that is subject
More informationPharmaceutical sales representatives access to physicians has. Pharma Rep Physician Access: Do Falling Numbers Point to New Sales Models?
ACCESSMONITOR 2013 EXECUTIVE SUMMARY Pharma Rep Physician Access: Do Falling Numbers Point to New Sales Models? Pharmaceutical sales representatives access to physicians has continuously declined over
More informationRemove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach
Remove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach When it comes to supporting the clinical and marketing objectives of any pharmaceutical franchise, helping to remove
More informationleading-edge insights for the global healthcare industry
leading-edge insights for the global healthcare industry We don t always choose the obvious route. But we always know the best one to choose. We know, because we re All Global Keeping you ahead of the
More informationCombating Fraud, Waste and Abuse
Combating Fraud, Waste and Abuse SPECIAL INVESTIGATIONS UNIT OUTSOURCING Fraud investigation is as complex as piecing together an intricate puzzle. Re-imagine Your Fraud, Waste and Abuse Management Strategy
More informationCombating Fraud, Waste and Abuse
Combating Fraud, Waste and Abuse SPECIAL INVESTIGATIONS UNIT OUTSOURCING Fraud investigation is as complex as piecing together an intricate puzzle. Re-imagine Your Fraud, Waste and Abuse Management Strategy
More informationSt. Luke s Hospital and Health Network Philosophy of Nursing:
St. Luke s Hospital and Health Network Philosophy of Nursing: Nursing, a healing profession, is an essential component of St. Luke's Hospital & Health Network's commitment to providing safe, compassionate,
More informationDepartment of Human Resources
Workforce Services Workforce Policy and Planning Department Management/ Human Resource Information Systems Employee Relations Employment Compensation and Workforce Analysis Employee Benefits Organizational
More informationThe agency perspective: What we do and how we do it
The agency perspective: What we do and how we do it Tim Ryder and Olga Dai 15 July 2011 Who are we? Tim Ryder Scientific Team Leader, Darwin HC MA in Biochemistry; DPhil in Physiology 10 years of experience
More informationUNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,
More informationRevenue Cycle Management Transformation
Revenue Cycle Management Transformation Daniel R. Frietze, Partner 1 Company at a Glance Offices: Virginia Beach, Virginia / Dallas, Texas Clients include: Integrated Delivery Networks Critical Access
More informationInstitute of Medicine Committee on Food Allergies Global Burden, Causes, Treatment, Prevention, and Public Policy
Institute of Medicine Committee on Food Allergies Global Burden, Causes, Treatment, Prevention, and Public Policy Mary Jane Marchisotto Senior Vice President, Research, FARE June 22, 2015 Presentation
More informationstrategy Therapure Biopharma is open for business P.20 HOW TO CHOOSE INSIGHTS FOR THE LIFE SCIENCE INDUSTRY DECEMBER 2008 Volume 11 Number 12
INSIGHTS FOR THE LIFE SCIENCE INDUSTRY DECEMBER 2008 Volume 11 Number 12 Therapure Biopharma is open for business P.20 HOW TO CHOOSE THE RIGHT outsourcing providers for your oncology clinical trials outsourcing
More informationStrategic Consulting Services
Services 1 Leadership Team Mark Levonyak President mlevonyak@davaonc.com Mobile: 214.460.5051 Martin W. Lee, MD EVP, Clinical Trial Services mlee@davaonc.com Mobile: 952.373.1405 John Eckardt, MD Chief
More informationEstablishing a Mature Identity and Access Management Program for a Financial Services Provider
Customer Success Stories TEKsystems Global Services Establishing a Mature Identity and Access Management Program for a Financial Services Provider FINANCIAL SERVICES NETWORK INFRASTRUCTURE SERVICES INFORMATION
More informationSelecting the Right Call Center Partner
Text for a pull out can go heretext for a pull out can go heretext for a pull out can go Text for a pull out can go here Text for a pull out can go here Selecting the Right Call Center Partner Nine Tips
More informationCopyright 2009 SAS Institute Inc. All rights reserved. Success With Business Analytics in the New Pharmaceutical Commercial Model.
Copyright 2009 SAS Institute Inc. All rights reserved. Success With Business Analytics in the New Pharmaceutical Commercial Model. Emerging Commercial Models: Rethinking Analytics Deloitte Consulting LLP
More informationNational Center for Healthcare Leadership SUMMARY. Health Leadership Competency Model
National Center for Healthcare Leadership Health Leadership Competency Model SUMMARY The NCHL Health Leadership Competency Model was created through research by the Hay Group with practicing health leaders
More informationPre-Questions. Mastering Clinical Research July 29, 2015
Pre-Questions Mastering Clinical Research July 29, 2015 1. To be compliant with SOP 2.1 Obtaining Informed Consent for greater than minimal risk interventional clinical trial, which Licensed Professional
More informationCapturing New Sources of Revenue with a Hospital-Owned Outpatient Pharmacy:
Capturing New Sources of Revenue with a Hospital-Owned Outpatient Pharmacy: A White Paper Providing Three Best Practices By Tracy W. Becker, PharmD, and Robert Ketchum, RPh, MS ABSTRACT Faced with another
More informationThe agency perspective
The agency perspective 16 January 2014 Anna Palmer Scientific Services Manager Contents What is medical communications? How did I get here? Medical communications vs other agencies What do we actually
More informationTeraCrunch Data Science Solutions & Services
TeraCrunch Data Science Solutions & Services Agenda Who is TeraCrunch Key Ingredients of Data Science & Big Data Analytics Projects Use Cases application of innovative analytics in Healthcare How to start
More informationNursing Professional Development Scope and Standards of Practice
Nursing Professional Development Scope and Standards of Practice Dora Bradley, PhD, RN-BC Vice President Nursing Professional Development Baylor Health Care System Dallas TX Objectives Discuss the critical
More informationWhat Lies Ahead? Trends to Watch: Health Care Product Development in North America
What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? for 2015 DIA has released its third annual What Lies Ahead? report, providing experts insights into the
More informationIntegrated Approach to Build Patient Adherence: Helping Pharmaceutical Companies to Enhance Growth
Cognizant White Paper Integrated Approach to Build Patient Adherence: Helping Pharmaceutical Companies to Enhance Growth Executive Summary Pharmaceutical companies have traditionally considered various
More informationOrganization and Job Profile
Organization and Job Profile New Orleans, Louisiana Position: Reports to: Location: System Vice President for Research New Orleans, Louisiana CORPORATE BACKGROUND is a non-profit, academic, multi-specialty,
More informationCase Study. Performance Testing of Medical Association Builder Portal. Case Study. US-based Non-profit Medical Association (Healthcare)
Performance Testing of Medical Association Builder Portal US-based Non-profit Medical Association (Healthcare) 1 2014 Compunnel Software Group Successful Web 2.0 Platform Launch with Compunnel s Performance
More informationDEVELOPMENTAL PROGRAMS BULLETIN COMMONWEALTH OF PENNSYLVANIA DEPARTMENT OF PUBLIC WELFARE
DEVELOPMENTAL PROGRAMS BULLETIN COMMONWEALTH OF PENNSYLVANIA DEPARTMENT OF PUBLIC WELFARE DATE OF ISSUE DRAFT EFFECTIVE DATE NUMBER SUBJECT: Health Care Quality Units BY: Kevin T. Casey Deputy Secretary
More informationParallel Session 2 Five Pillars to succes A framework for approaching market research in Emerging Markets
Parallel Session 2 Five Pillars to succes A framework for approaching market research in Emerging Markets Steve Kretschmer, Ipsos, Turkey and Beyza Ozel, Novartis, Turkey 5 Pillars to Success: A Framework
More information74% of physicians responded yes when asked if they are currently using an EHR system.
Page 1 An EHR Overview for Pharma Marketers EHR Overview An electronic health record (EHR) is a secure software system that replaces the paper based patient record system. The EHR is used by the provider
More informationCertified Specialty Pharmacist (CSP ) Job Analysis Executive Summary
Certified Specialty Pharmacist (CSP ) Job Analysis Executive Summary April 2013 The Specialty Pharmacy Certification Board (SPCB) contracted with Comira Testing, to develop the examination component of
More informationCharting the Future of Primary Care: Care Coordination/Case Management
Charting the Future of Primary Care: Care Coordination/Case Management ASA-NYAM Forum March 19, 2009 Cheryl Schraeder, RN, PhD Director of Policy & Practice Initiatives Institute for Healthcare Innovation
More informationFDA STAFF MANUAL GUIDES, VOLUME I ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS OFFICE OF HUMAN RESOURCES
SMG 1117.33 FDA STAFF MANUAL GUIDES, VOLUME I ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS OFFICE OF HUMAN RESOURCES DIVISION OF POLICY, PROGRAMS, AND EXECUTIVE RESOURCES
More information3 rd Asia Pacific Pharmaceutical Compliance Congress And Best Practices Forum Sept 10-12 2013, Kuala Lumpur, Malaysia
3 rd Asia Pacific Pharmaceutical Compliance Congress And Best Practices Forum Sept 10-12 2013, Kuala Lumpur, Malaysia Mai Tran COMPLIANCE ISSUES IN SOCIAL MEDIA AND DIGITAL MARKETING Social media landscape
More informationImplementing a Life Sciences Sales Force
A Process and Tactical Blueprint Implementing a Life Sciences Sales Force A Publicis Touchpoint Solutions White Paper Best Practices Series 2011 Publicis Touchpoint Solutions, Inc. Implementing a Life
More informationREMS: The New Reality
Kuyler Doyle, Principal Consultant, Campbell Alliance Jay Jauregui, Senior Practice Executive, Trade and Distribution Practice Gary Tyson, Senior Vice President, Clinical Development and Medical Affairs
More information